Related Experiment Video
Updated: Jan 4, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
Parent testimonial: A caregiver whose son with inhibitors has been receiving emicizumab
1National Director of Health Policy Canadian Hemophilia Society Montreal, Canada.
Abstract:
Emicizumab, grantted via compassionate access, has transformed the life of my son. Prior to receiving emicizumab, he was hospitalized and no therapies were effective in stopping his bleeding. Since the start of emicizuamb treatment, he has had no bleeds and has started doing many activities like a normal boy.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Hemodialysis II: Procedure and Complications
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care

